Obermatt

Agilent

NYQ:A · US00846U1016
Life Sciences Tools & ServicesX-Large

360

89
EV / EBIT62
Price / Owner Earnings38
Owner Earnings Yield81
Dividend Yield99
Price/Sales40
EV / Gross Profit45
Price/Book27
Return on Capital85
Cash Return on Capital85
Return on Equity88
EBIT Margin81
Gross Profitability77
Cash Conversion11
Accruals31
Owner Earnings Margin85
Sales growth60
Profit Growth94
Long-Term EPS Growth42
Owner Earnings Growth65
Reinvestment40
Price momentum49
Debt load40
Refinancing39
Debt Payback59
Liquidity93
Analyst ratings69
Opinion Changes69
Price Target Upside65
Market mood85
Value Creation16/20strong value creator
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Agilent generates returns well above its cost of capital, the foundation of durable shareholder value.

Profile

CountryUSA
IndustryLife Sciences Tools & Services
SizeX-Large
TypePublic Company
ExchangeNYSE
Founded1999
Employees16,175
ISINUS00846U1016
Last UpdateApr 2, 2026
Themes
Health DiagnosticsGeneticsBiomedical EngineeringProcess AutomationOnline Analysis and ReferenceEnvironmental ConsultingDetectors, Sensors and MemsBiotechnologyHealth CareScience and Engineering

Description

Agilent Technologies, Inc. (Agilent) operates in the life sciences, diagnostics and applied markets, providing application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. In November…

Analysis

Middle-of-the-road

Agilent Technologies, Inc. sits in the middle of our grid: average quality, average price, no obvious signal in either direction. Worth noting: the cash the business generates has lagged behind what the income statement shows.

On valuation, the picture is expensive. The owner-earnings multiple stands at 27.6×; owner earnings: the cash an owner could take out each year. The implied growth embedded in that price is around 11% a year, against analyst forecasts of 10%. The price, in other words, assumes less than the experts do.

Growth is moderate; the safety picture is sturdy. The company scores 16/20 on our value-creation score: strong value creator.

Flags to be aware of: Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
100
2023202420252026

All-time high

100

Jun 2026

All-time low

53

Jan 2023

Average rank

75

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
40
30
25
58
Price/Earnings
40
56
55
43
Price/Book
27
16
21
34
Dividend Yield
99
97
94
95
Value (overall)
71
75
67
91

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Agilent with its peers
Bio-Techne
NSQ:TECH
74
CountryUSA
IndustryLife Sciences Tools & Services
SizeLarge
Full Stock Analysis →
Quanterix
NMQ:QTRX
43
CountryUSA
IndustryLife Sciences Tools & Services
SizeSmall
Full Stock Analysis →
Revvity
NYQ:RVTY
52
CountryUSA
IndustryLife Sciences Tools & Services
SizeLarge
Full Stock Analysis →
Bio-Rad Laboratories
NYQ:BIO
48
CountryUSA
IndustryLife Sciences Tools & Services
SizeLarge
Full Stock Analysis →
Avantor
NYQ:AVTR
13
CountryUSA
IndustryLife Sciences Tools & Services
SizeX-Large
Full Stock Analysis →
Seer
NSQ:SEER
43
CountryUSA
IndustryLife Sciences Tools & Services
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →